FOX
71
3
PFE
37
4
AAP
26
5
DRI
74
5
USB
50
3
SRE
37
9
SYK
50
4
PH
60
5
DLTR
52
8
KIM
58
2
NTRS
35
10
ADT
12
2
SHW
42
5
CAG
34
3
SNA
56
3
LNC
28
3
KSS
36
2
VNO
46
6
FAST
41
7
STZ
42
2
FOX
71
3
PFE
37
4
AAP
26
5
DRI
74
5
USB
50
3
SRE
37
9
SYK
50
4
PH
60
5
DLTR
52
8
KIM
58
2
NTRS
35
10
ADT
12
2
SHW
42
5
CAG
34
3
SNA
56
3
LNC
28
3
KSS
36
2
VNO
46
6
FAST
41
7
STZ
42
2
Financhill
Back

Madrigal Pharmaceuticals 10K Form

Sell
50

MDGL
Madrigal Pharmaceuticals

Last Price:
$306.37
Seasonality Move:
15.43%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive MDGL News And Ratings

See the #1 stock for the next 7 days that we like better than MDGL

MDGL Financial Statistics

Sales & Book Value

Annual Sales: $147K
Cash Flow: $-67.8M
Price / Cash Flow: 0
Annual Sales: $35.64
Price / Book: 8.66

Profitability

EPS (TTM): -25.12000
Net Income (TTM): $-518.7M
Gross Margin: $0
Return on Equity: -89.04%
Return on Assets: -62.74%

Madrigal Pharmaceuticals Earnings Forecast

Key Madrigal Pharmaceuticals Financial Ratios

  • The Selling, General & Administrative Expenses for MDGL have been equal to 7,942.86% of Gross Profit Margin.
  • The Interest Expense is -3.40% of Operating Income.
  • Per Share Earnings over the last 23 years have been positive in 8 years.

Madrigal Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: MDGL
CUSIP: 558868
Website: madrigalpharma.com

Debt

Debt-to-Equity Ratio: 0.15
Current Ratio: 5.98
Quick Ratio: 5.79

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

MDGL Technical Analysis vs Fundamental Analysis

Sell
50
Madrigal Pharmaceuticals (MDGL) is a Sell

Is Madrigal Pharmaceuticals a Buy or a Sell?